FDA approves Kaleo’s allergy auto-injector designed for infants

This article was originally published here
Share

kaleoThe FDA has approved Kaleo‘s Auvi-Q epinephrine auto-injector designed to treat life-threatening allergic reactions in infants and small children, according to the privately-held biopharma company.

The device, which Kaleo touts as the first of its kind, was given priority review by the FDA.

Get the full story at our sister site, Drug Delivery Business News.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply